APO-LEFLUNOMIDE leflunomide 20mg tablets bottle

País: Austràlia

Idioma: anglès

Font: Department of Health (Therapeutic Goods Administration)

ingredients actius:

leflunomide, Quantity: 20 mg

Disponible des:

Arrotex Pharmaceuticals Pty Ltd

Designació comuna internacional (DCI):

Leflunomide

formulario farmacéutico:

Tablet, uncoated

Composición:

Excipient Ingredients: colloidal anhydrous silica; lactose; magnesium stearate; crospovidone

Vía de administración:

Oral

Unidades en paquete:

30 tablets

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

Apo-Leflunomide is indicated for the treatment of active rheumatoid arthritis. The combined use of Apo-Leflunomide with other disease modifying antirheumatic drugs (DMARDs) has not been adequately studied (see Precautions).

Resumen del producto:

Visual Identification: White, arc-triangular shaped tablet. Engraved "LE" over "20" on one side and "APO" on the other side.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Estat d'Autorització:

Licence status A

Data d'autorització:

2011-07-22